NAV

Peptide YY (3-36)

Targets (4)

Identification

Name
Peptide YY (3-36)
Accession Number
DB05004
Description

Peptide YY (3-36), a synthetic human PYY 3-36, is a compound being evaluated for the treatment of obesity. It reduces appetite and increases satiety in obese patients.

Type
Small Molecule
Groups
Investigational
Synonyms
  • Pyy (3-36) peptide
  • PYY 3-36
  • PYY(3-36)
  • PYY3-36
External IDs
  • AC162352
  • GT-001

Pharmacology

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Indication

Investigated for use/treatment in metabolic disease and obesity.

Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics
Not Available
Mechanism of action

PYY 3-36 acts via the presynaptic Y2 receptor in the ARC. It decreases neuropeptide Y (NPY) release from static hypothalamic explants and thus acts to decrease food intake.

TargetActionsOrganism
UNeuropeptide Y receptor type 2Not AvailableHumans
UNeuropeptide Y receptor type 1Not AvailableHumans
UNeuropeptide Y receptor type 5Not AvailableHumans
UNeuropeptide Y receptor type 4Not AvailableHumans
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
7PQZ90ULIR
CAS number
123583-37-9

References

General References
  1. Chandarana K, Batterham R: Peptide YY. Curr Opin Endocrinol Diabetes Obes. 2008 Feb;15(1):65-72. doi: 10.1097/MED.0b013e3282f3f4b1. [PubMed:18185065]
  2. Sloth B, Davidsen L, Holst JJ, Flint A, Astrup A: Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males. Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E604-9. Epub 2007 Jun 12. [PubMed:17566112]
PubChem Substance
347909887

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2CompletedTreatmentBMI >30 kg/m21
1CompletedTreatmentFeeding and Eating Disorders1
1CompletedTreatmentHealthy Volunteers1
0CompletedBasic ScienceHealthy Volunteers1
Not AvailableCompletedTreatmentBMI >30 kg/m21

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Targets

Drugtargets
Accelerate your drug discovery research
with our fully connected ADMET & drug target dataset.
Learn more
Accelerate your drug discovery research with our ADMET & drug target dataset
Learn more
Details1. Neuropeptide Y receptor type 2
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Receptor activity
Specific Function
Receptor for neuropeptide Y and peptide YY. The rank order of affinity of this receptor for pancreatic polypeptides is PYY > NPY > PYY (3-36) > NPY (2-36) > [Ile-31, Gln-34] PP > [Leu-31, Pro-34] N...
Gene Name
NPY2R
Uniprot ID
P49146
Uniprot Name
Neuropeptide Y receptor type 2
Molecular Weight
42730.69 Da
Details2. Neuropeptide Y receptor type 1
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Peptide yy receptor activity
Specific Function
Receptor for neuropeptide Y and peptide YY. The rank order of affinity of this receptor for pancreatic polypeptides is NPY > [Pro-34] PYY, PYY and [Leu-31, Pro-34] NPY > NPY (2-36) > [Ile-31, Gln-3...
Gene Name
NPY1R
Uniprot ID
P25929
Uniprot Name
Neuropeptide Y receptor type 1
Molecular Weight
44391.535 Da
Details3. Neuropeptide Y receptor type 5
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Peptide yy receptor activity
Specific Function
Receptor for neuropeptide Y and peptide YY. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity. Seems to be associated with food intake. Could be involv...
Gene Name
NPY5R
Uniprot ID
Q15761
Uniprot Name
Neuropeptide Y receptor type 5
Molecular Weight
50725.99 Da
Details4. Neuropeptide Y receptor type 4
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Peptide yy receptor activity
Specific Function
Receptor for neuropeptide Y and peptide YY. The rank order of affinity of this receptor for pancreatic polypeptides is PP, PP (2-36) and [Ile-31, Gln-34] PP > [Pro-34] PYY > PYY and [Leu-31, Pro-34...
Gene Name
NPY4R
Uniprot ID
P50391
Uniprot Name
Neuropeptide Y receptor type 4
Molecular Weight
42194.55 Da

Drug created on October 21, 2007 22:23 / Updated on June 12, 2020 16:52